E. Di Bona

1.7k total citations
21 papers, 973 citations indexed

About

E. Di Bona is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, E. Di Bona has authored 21 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Genetics and 5 papers in Surgery. Recurrent topics in E. Di Bona's work include Platelet Disorders and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). E. Di Bona is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). E. Di Bona collaborates with scholars based in Italy, Malaysia and Greece. E. Di Bona's co-authors include Francesco Rodeghiero, Giancarlo Castaman, Marco Ruggeri, A. Gabbas, Paola Saracco, Andrea Bacigalupo, Anna Locasciulli, Carlo Dufour, Benedetto Bruno and Marco Ruggeri and has published in prestigious journals such as Blood, Annals of Oncology and British Journal of Haematology.

In The Last Decade

E. Di Bona

21 papers receiving 939 citations

Peers

Countries citing papers authored by E. Di Bona

Since Specialization

Citations

This map shows the geographic impact of E. Di Bona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Di Bona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Di Bona more than expected).

Fields of papers citing papers by E. Di Bona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Di Bona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Di Bona. The network helps show where E. Di Bona may publish in the future.

Co-authorship network of co-authors of E. Di Bona

This figure shows the co-authorship network connecting the top 25 collaborators of E. Di Bona. A scholar is included among the top collaborators of E. Di Bona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Di Bona. E. Di Bona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program 2013 ·Haematologica ·Tamara Intermesoli, Alessandro Rambaldi, Giuseppe Rossi, Federica Delaini, Claudio Romani, Enrico Maria Pogliani, Chiara Pagani, Emanuele Angelucci, Elisabetta Terruzzi, Alessandro Levis, Vincenzo Cassibba, Daniele Mattei, Giacomo Gianfaldoni, (unknown), E. Di Bona, (unknown), (unknown), Nicola Gökbuget, R Bassan	34
2	Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study 2012 ·Haematologica ·Livio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni, Simona Fisogni, (unknown), Francesco Mannelli, Monia Lunghi, Gian-Matteo Pica, Francesco Onida, Chiara Cattaneo, Pier Paolo Piccaluga, E. Di Bona, Elisabetta Todisco, Pellegrino Musto, Antonio Spadea, Alfonso Maria D’Arco, S Pileri, Giuseppe Leone, Sergio Amadori, Fabio Facchetti, (unknown)	208
3	New potential markers of severe thrombo-hemorrhagic syndrome (THS) in acute promyelocytic leukemia (APL) patients: activated FVII-antithrombin complex (FVIIa-AT) and Tissue Factor (TF) mRNA 2012 ·Thrombosis Research ·М. Marchetti, Laura Russo, Carmen Julia Tartari, Barry Woodhams, E. Di Bona, Alessandro Rambaldi, (unknown), Anna Falanga	2
4	Short-course imatinib (IM) added to chemotherapy improves early but not long-term outcome in adult Ph/BCR-ABL+ acute lymphoblastic leukemia (ALL) : 5-year follow-up results of study NILG-09 2008 ·Haematologica ·R Bassan, Tamara Intermesoli, Elena Oldani, G. Rossi, Erika Borlenghi, (unknown), Elisabetta Terruzzi, P Fabris, E. Di Bona, Giacomo Gianfaldoni, Claudio Romani, Agostino Cortelezzi, Daniele Mattei, Orietta Spinelli, Alessandro Rambaldi	4
5	Genomic gain at 6p21: a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemia 2006 ·Leukemia ·Roberta La Starza, Anna Aventı́n, Caterina Matteucci, Barbara Crescenzi, (unknown), Nicoletta Testoni, V. Pierini, Stefania Ciolli, Constantina Sambani, Anna Locasciulli, E. Di Bona, Mårina Lafage‐Pochitaloff, Maria Paola Martelli, Peter Marynen, Cristina Mecucci	6
6	NK/T-cell lymphomas ‘nasal type’: an Italian multicentric retrospective survey 2006 ·Annals of Oncology ·Livio Pagano, Andrea Gallamini, Giulio Trapè, Luana Fianchi, Daniele Mattei, G Todeschini, Antonio Spadea, Saverio Cinieri, Emilio Iannitto, Maurizio Martelli, A. Nosari, E. Di Bona, Maria Elena Tosti, Maria Concetta Petti, Paolo Falcucci, Marco Montanaro, Alessandro Pulsoni, Luigi Maria Larocca, Giuseppe Leone	56
7	Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients 2000 ·Blood ·Andrea Bacigalupo, Benedetto Bruno, Paola Saracco, E. Di Bona, Anna Locasciulli, Francesco Locatelli, A. Gabbas, Carlo Dufour, William Arcese, Gabriele Testi, G Broccia, M Carotenuto, P Coser, Tiziano Barbui, Pietro Leoni, A. Ferster	213
8	Rabbit antithymocyte globulin (r‐ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy 1999 ·British Journal of Haematology ·E. Di Bona, Francesco Rodeghiero, Benedetto Bruno, A. Gabbas, P. Foa, Anna Locasciulli, (unknown), Lionello Camba, Paola Saracco, A. Lippi, Anna Paola Iori, Fulvio Porta, (unknown), Benedetto Comotti, Pasquale Iacopino, Carlo Dufour, Andrea Bacigalupo	123
9	Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA Archive of Adult Acute Leukaemia 1999 ·British Journal of Haematology ·Livio Pagano, Alessandro Pulsoni, Maria Elena Tosti, Luciana Annino, Alfonso Mele, Andrea Camera, B. Martino, Cosimo Guglielmi, R Cerri, E. Di Bona, Rosangela Invernizzi, (unknown), Renato Bassan, Luca Mele, G Todeschini, Giuseppe Leone, F Mandelli	57
10	Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies. 1998 ·PubMed ·Giancarlo Castaman, E. Di Bona, (unknown), Livio Trentin, Anna D’Emilio, Francesco Rodeghiero	17
11	Acquired haemophilia: experience of two Italian centres with 17 new cases 1997 ·Haemophilia ·E. Di Bona, M. Schiavoni, Giancarlo Castaman, N. Ciavarella, Francesco Rodeghiero	28
12	Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma. 1997 ·PubMed ·Teresa Lerede, Renato Bassan, Anita De Rossi, E. Di Bona, Giuseppe Rossi, Enrico Maria Pogliani, T. Motta, Valter Torri, M Buelli, Benedetto Comotti, Piera Viero, Alessandro Rambaldi, (unknown), Francesco Rodeghiero, Tiziano Barbui	10
13	The role of anthracyclines in adult acute lymphoblastic leukaemia. 1996 ·PubMed ·Renato Bassan, Teresa Lerede, Alessandro Rambaldi, E. Di Bona, Giuseppe Rossi, Enrico Pogliani, G. Lambertenghi‐Deliliers, Antonio Porcellini, P Fabris, T Barbui	7
14	The Outbreak of Hepatitis A in Italian Patients with Hemophilia: Facts and Fancies 1994 ·Vox Sanguinis ·Pier Mannuccio Mannucci, Elena Santagostino, E. Di Bona, (unknown), Alessandro Ghirardini, (unknown), (unknown)	18
15	Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy 1989 ·Annals of Hematology ·Giancarlo Castaman, Francesco Rodeghiero, E. Di Bona, Marco Ruggeri	17
16	Triton X contaminating platelet lysate critically affects the measurement of von Willebrand factor ristocetin cofactor activity 1989 ·Thrombosis Research ·Francesco Rodeghiero, Giancarlo Castaman, Alberto Tosetto, Marco Ruggeri, E. Di Bona	4
17	Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia A 1989 ·Blood ·Francesco Rodeghiero, Giancarlo Castaman, E. Di Bona, Marco Ruggeri	44
18	Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia A 1989 ·Blood ·Francesco Rodeghiero, Giancarlo Castaman, E. Di Bona, Marco Ruggeri	56
19	Hyper‐responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra‐platelet von Willebrand factor 1988 ·European Journal Of Haematology ·Francesco Rodeghiero, Giancarlo Castaman, E. Di Bona, Marco Ruggeri, R Lombardi, P.M. Mannucci	31
20	Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy 1987 ·Annals of Hematology ·Francesco Rodeghiero, Giancarlo Castaman, E. Di Bona, Marco Ruggeri, E Dini	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact